BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LNCB74 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of LNCB74\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06774963-2595@assetmemo.bio
DTSTAMP:20261121T005406Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:LNCB74: Phase 1 readout est. (NCT06774963)
DESCRIPTION:LNCB74\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Phase 
 1 Study of LNCB74 in Advanced Solid Tumors\nEstimated primary completion: 
 December 2027. This is a ClinicalTrials.gov estimate\, not a confirmed rea
 dout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/lncb74
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT067
 74963
URL:https://assetmemo.bio/drug/lncb74#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
